OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, has closed a new fund with a total of $170 million. OTV also announced their new name and the appointment of a new Head of Asia Pacific (with an office in China) to spearhead the fund’s expansion there.
OTV claims to be the only VC fund in Israel whose primary focus is digital health, specialising in supporting their portfolio companies reach maturity, refine execution, tackle regulatory hurdles and ensure a global imprint on validated products. The fund’s portfolio includesTytoCare (which raised $50 million back in April), Lemonaid Health, Emedgene, Scopio and Donisi Health.
Founded in 2015, the firm has offices in New York, Tel Aviv and Montreal, with investments spanning across Israel, the US, Latin America and Asia. In fact, to expand in the latter market, the firm has named Jose Antonio Urrutia Rivas as Head of Asia Pacific, and he’ll be based in China.
Photo: Founders and General Partners Mayer Gniwisch, Amir Lahat and Alejandro Weinstein